MedTrace Logo

Predicting Outcome in Cervix Carcinoma: a Prospective Study

NCT01825005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 423

Last updated 2019-05-10

No results posted yet for this study

Summary

The main aim is to validate and improve the predictive model for survival and toxicity in patients with cervical cancer through multicentric prospective data collection. The data contain information on patient, tumor and treatment characteristics. For this study, additional health related QOL scores will be assessed using the EORTC Quality of Life Questionair-CX24 and C30. The long term aim, beyond this specific study, is to build a Decision Support System based on the predictive model validated in this study.

Conditions

Sponsors & Collaborators

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • P Lambin, Prof · Maastricht University hospital, dep of radiotherapy (Maastro clinic)

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Netherlands
  • South Africa

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01825005 on ClinicalTrials.gov